Published in Structure on February 15, 1997
High resolution crystal structure of human β-glucuronidase reveals structural basis of lysosome targeting. PLoS One (2013) 1.58
A superfamily of metalloenzymes unifies phosphopentomutase and cofactor-independent phosphoglycerate mutase with alkaline phosphatases and sulfatases. Protein Sci (1998) 1.54
Distinct and essential morphogenic functions for wall- and lipo-teichoic acids in Bacillus subtilis. EMBO J (2009) 1.43
Sequence determinants directing conversion of cysteine to formylglycine in eukaryotic sulfatases. EMBO J (1999) 1.31
Conversion of cysteine to formylglycine: a protein modification in the endoplasmic reticulum. Proc Natl Acad Sci U S A (1997) 1.13
Cloning of a mucin-desulfating sulfatase gene from Prevotella strain RS2 and its expression using a Bacteroides recombinant system. J Bacteriol (2000) 1.10
Functional consequences of the subdomain organization of the sulfs. J Biol Chem (2009) 1.10
Lysophospholipid interactions with protein targets. Biochim Biophys Acta (2008) 1.08
Escherichia coli K1 aslA contributes to invasion of brain microvascular endothelial cells in vitro and in vivo. Infect Immun (2000) 1.07
A review of coumarin derivatives in pharmacotherapy of breast cancer. Curr Med Chem (2008) 1.03
Genetic and functional analyses of PptA, a phospho-form transferase targeting type IV pili in Neisseria gonorrhoeae. J Bacteriol (2007) 1.01
Cell-surface arylsulfatase A and B on sinusoidal endothelial cells, hepatocytes, and Kupffer cells in mammalian livers. Med Mol Morphol (2009) 0.99
Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia. PLoS One (2012) 0.97
The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A. J Mol Biol (2012) 0.95
Oligomeric structure of proclavaminic acid amidino hydrolase: evolution of a hydrolytic enzyme in clavulanic acid biosynthesis. Biochem J (2002) 0.93
Heparin/heparan sulfate N-sulfamidase from Flavobacterium heparinum: structural and biochemical investigation of catalytic nitrogen-sulfur bond cleavage. J Biol Chem (2009) 0.93
Several cooperating binding sites mediate the interaction of a lysosomal enzyme with phosphotransferase. EMBO J (1997) 0.90
Formylglycine, a post-translationally generated residue with unique catalytic capabilities and biotechnology applications. ACS Chem Biol (2015) 0.89
Modeling catalytic promiscuity in the alkaline phosphatase superfamily. Phys Chem Chem Phys (2013) 0.89
Effect of 'attenuated' mutations in mucopolysaccharidosis IVA on molecular phenotypes of N-acetylgalactosamine-6-sulfate sulfatase. J Inherit Metab Dis (2007) 0.89
Crystal structures of all-alpha type membrane proteins. Eur Biophys J (2009) 0.88
Post-Synthetic Regulation of HS Structure: The Yin and Yang of the Sulfs in Cancer. Front Oncol (2014) 0.88
Characterization of glycosaminoglycan (GAG) sulfatases from the human gut symbiont Bacteroides thetaiotaomicron reveals the first GAG-specific bacterial endosulfatase. J Biol Chem (2014) 0.87
Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis. J Inherit Metab Dis (2006) 0.87
Structure and molecular mechanism of Bacillus anthracis cofactor-independent phosphoglycerate mutase: a crucial enzyme for spores and growing cells of Bacillus species. Biophys J (2006) 0.85
Sulfatase activities towards the regulation of cell metabolism and signaling in mammals. Cell Mol Life Sci (2009) 0.84
Synthesis and evaluation of general mechanism-based inhibitors of sulfatases based on (difluoro)methyl phenyl sulfate and cyclic phenyl sulfamate motifs. Bioorg Med Chem (2006) 0.82
Processing of normal lysosomal and mutant N-acetylgalactosamine 4-sulphatase: BiP (immunoglobulin heavy-chain binding protein) may interact with critical protein contact sites. Biochem J (1999) 0.82
Aromatase, estrone sulfatase, and 17β-hydroxysteroid dehydrogenase: structure-function studies and inhibitor development. Mol Cell Endocrinol (2010) 0.81
Segregation analysis in a family at risk for the Maroteaux-Lamy syndrome conclusively reveals c.1151G>A (p.S384N) as to be a polymorphism. Eur J Hum Genet (2009) 0.81
Biochemical characterization of arylsulfatase E and functional analysis of mutations found in patients with X-linked chondrodysplasia punctata. Am J Hum Genet (1998) 0.80
Analysis of normal and mutant iduronate-2-sulphatase conformation. Biochem J (2005) 0.80
Arylsulfatase K, a novel lysosomal sulfatase. J Biol Chem (2013) 0.79
Mutagenic analysis of conserved arginine residues in and around the novel sulfate binding pocket of the human Theta class glutathione transferase T2-2. Protein Sci (1999) 0.78
Molecular characterization of arylsulfatase G: expression, processing, glycosylation, transport, and activity. J Biol Chem (2014) 0.78
Cloning and characterization of a novel chondroitin sulfate/dermatan sulfate 4-O-endosulfatase from a marine bacterium. J Biol Chem (2015) 0.78
Overexpression of inactive arylsulphatase mutants and in vitro activation by light-dependent oxidation with vanadate. Biochem J (2004) 0.77
Identification of a common mutation (R245H) in Sanfilippo A patients from The Netherlands. J Inherit Metab Dis (1998) 0.76
Enzyme-Assisted Preparation of Furcellaran-Like κ-/β-Carrageenan. Mar Biotechnol (NY) (2015) 0.76
Neutralizing the anticoagulant activity of ultra-low-molecular-weight heparins using N-acetylglucosamine 6-sulfatase. FEBS J (2013) 0.75
Glycosulfatase-Encoding Gene Cluster in Bifidobacterium breve UCC2003. Appl Environ Microbiol (2016) 0.75
Molecular findings of Colombian patients with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Meta Gene (2015) 0.75
Mutations in ARSB in MPS VI patients in India. Mol Genet Metab Rep (2015) 0.75
Clinical and morphological features including expression of betaig-h3 and keratan sulphate proteoglycans in Maroteaux-Lamy syndrome type B and in normal cornea. Br J Ophthalmol (2002) 0.75
Novel mutations of the arylsulphatase B (ARSB) gene in Indian patients with mucopolysaccharidosis type VI. Indian J Med Res (2015) 0.75
Comparative studies of vertebrate iduronate 2-sulfatase (IDS) genes and proteins: evolution of A mammalian X-linked gene. 3 Biotech (2017) 0.75
The functional consequences of mis-sense mutations affecting an intra-molecular salt bridge in arylsulphatase A. Biochem J (2002) 0.75
Proteomic analysis of scallop hepatopancreatic extract provides insights into marine polysaccharide digestion. Sci Rep (2016) 0.75
Matching the Diversity of Sulfated Biomolecules: Creation of a Classification Database for Sulfatases Reflecting Their Substrate Specificity. PLoS One (2016) 0.75
Chondroitin sulfate/dermatan sulfate sulfatases from mammals and bacteria. Glycoconj J (2016) 0.75
Molecular analysis of the novel IDS allele in a Thai family with mucopolysaccharidosis type II: The c.928C>T (p.Gln310*) transcript is sensitive to nonsense-mediated mRNA decay. Exp Ther Med (2017) 0.75
Prevalence of lysosomal storage disorders. JAMA (1999) 9.06
Structure of oxidized poplar plastocyanin at 1.6 A resolution. J Mol Biol (1983) 2.41
Huntington disease-linked locus D4S111 exposed as the alpha-L-iduronidase gene. Somat Cell Mol Genet (1991) 2.23
Three-dimensional structures of Drosophila melanogaster acetylcholinesterase and of its complexes with two potent inhibitors. Protein Sci (2000) 1.99
The binding site of acetylcholine receptor as visualized in the X-Ray structure of a complex between alpha-bungarotoxin and a mimotope peptide. Neuron (2001) 1.96
Chromosomal localization of ARSB, the gene for human N-acetylgalactosamine-4-sulphatase. Hum Genet (1989) 1.95
Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc Natl Acad Sci U S A (1990) 1.91
Glycosaminoglycan synthesis by cultured human skin fibroblasts after transformation with simian virus 40. J Biol Chem (1977) 1.77
Crystal structure of a heptameric Sm-like protein complex from archaea: implications for the structure and evolution of snRNPs. J Mol Biol (2001) 1.71
A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome). Glycobiology (1999) 1.67
Diagnosis of Maroteaux-Lamy syndrome by the use of radiolabelled oligosaccharides as substrates for the determination of arylsulphatase B activity. Biochem J (1986) 1.61
Structures of D-xylose isomerase from Arthrobacter strain B3728 containing the inhibitors xylitol and D-sorbitol at 2.5 A and 2.3 A resolution, respectively. J Mol Biol (1989) 1.61
Genetic mapping of new RFLPs at Xq27-q28. Genomics (1991) 1.60
Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications. Hum Mutat (1995) 1.54
Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications. Hum Mutat (2001) 1.52
Human liver iduronate-2-sulphatase. Purification, characterization and catalytic properties. Biochem J (1990) 1.50
The molecular-weight distribution of glycosaminoglycans. Biochem J (1973) 1.48
Human alpha-L-iduronidase: cDNA isolation and expression. Proc Natl Acad Sci U S A (1991) 1.48
alpha-L-iduronidase, beta-D-glucuronidase, and 2-sulfo-L-iduronate 2-sulfatase: preparation and characterization of radioactive substrates from heparin. Carbohydr Res (1979) 1.45
Crystal structures of the copper-containing amine oxidase from Arthrobacter globiformis in the holo and apo forms: implications for the biogenesis of topaquinone. Biochemistry (1997) 1.45
High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidoses. Anal Biochem (1982) 1.43
Crystal structure analyses of reduced (CuI) poplar plastocyanin at six pH values. J Mol Biol (1986) 1.43
Enzymatic diagnosis of the mucopolysaccharidoses: experience of 96 cases diagnosed in a five-year period. Med J Aust (1982) 1.41
Coexistence of Gaucher disease type 1 and Joubert syndrome. J Med Genet (1998) 1.40
Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age--a sibling control study. Clin Genet (2009) 1.39
Human alpha-L-iduronidase. 1. Purification, monoclonal antibody production, native and subunit molecular mass. Eur J Biochem (1985) 1.39
The alkaline cleavage and borohydride reduction of cartilage proteoglycan. Biochem J (1973) 1.36
Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation. Hum Mol Genet (2001) 1.36
Human N-acetylgalactosamine-4-sulphate sulphatase. Purification, monoclonal antibody production and native and subunit Mr values. Biochem J (1987) 1.34
Human liver sulphamate sulphohydrolase. Determinations of native protein and subunit Mr values and influence of substrate agylcone structure on catalytic properties. Biochem J (1986) 1.33
Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes. Am J Hum Genet (1994) 1.33
Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase. Biochem J (1992) 1.32
Structure and sequence of the human alpha-L-iduronidase gene. Genomics (1992) 1.32
Crystal structure of the epsilon subunit of the proton-translocating ATP synthase from Escherichia coli. Structure (1997) 1.30
Crystal structure of a eukaryotic (pea seedling) copper-containing amine oxidase at 2.2 A resolution. Structure (1996) 1.29
Hyaluronic acid: molecular conformations and interactions in two sodium salts. J Mol Biol (1975) 1.29
A strategy for rapid sequencing of heparan sulfate and heparin saccharides. Proc Natl Acad Sci U S A (1999) 1.27
Highly sensitive sequencing of the sulfated domains of heparan sulfate. J Biol Chem (1999) 1.27
A fluorometric assay using 4-methylumbelliferyl alpha-L-iduronide for the estimation of alpha-L-iduronidase activity and the detection of Hurler and Scheie syndromes. Clin Chim Acta (1979) 1.27
The alkali-labile linkage between keratan sulphate and protein. Biochem J (1974) 1.27
Human alpha-L-iduronidase. 2. Catalytic properties. Eur J Biochem (1985) 1.26
Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome. J Clin Invest (1996) 1.24
Immunopurification and characterization of human alpha-L-iduronidase with the use of monoclonal antibodies. Biochem J (1989) 1.24
Cloning and expression of the gene involved in Sanfilippo B syndrome (mucopolysaccharidosis III B). Hum Mol Genet (1996) 1.22
The diagnosis of the Sanfilippo C syndrome, using monosaccharide and oligosaccharide substrates to assay acetyl-CoA: 2-amino-2-deoxy-alpha-glucoside N-acetyltransferase activity. Clin Chim Acta (1981) 1.22
Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease. Clin Chem (2001) 1.22
Human liver N-acetylglucosamine-6-sulphate sulphatase. Purification and characterization. Biochem J (1987) 1.21
Identification of mutations in the alpha-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes. Am J Hum Genet (1993) 1.18
Mucopolysaccharidosis type I: identification of 8 novel mutations and determination of the frequency of the two common alpha-L-iduronidase mutations (W402X and Q70X) among European patients. Hum Mol Genet (1994) 1.18
Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulphatase enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): a phase I/II study. Acta Paediatr Suppl (2005) 1.18
Recombinant human iduronate-2-sulphatase: correction of mucopolysaccharidosis-type II fibroblasts and characterization of the purified enzyme. Biochem J (1993) 1.17
Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes. Eur J Hum Genet (1999) 1.17
A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype. Hum Mutat (1992) 1.17
Diagnosis of Sanfilippo type A syndrome by estimation of sulfamidase activity using a radiolabelled tetrasaccharide substrate. Clin Chim Acta (1982) 1.17
Human liver N-acetylglucosamine-6-sulphate sulphatase. Catalytic properties. Biochem J (1987) 1.16
Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome. Hum Genet (1991) 1.15
Biochemical discrimination of Hurler and Scheie syndromes. Clin Sci (Lond) (1979) 1.13
Structure and mechanism of a proline-specific aminopeptidase from Escherichia coli. Proc Natl Acad Sci U S A (1998) 1.13
Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome. Nat Genet (1995) 1.13
alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype. Hum Mutat (1992) 1.12
Enzyme replacement therapy in a feline model of MPS VI: modification of enzyme structure and dose frequency. Pediatr Res (2000) 1.12
Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype. J Inherit Metab Dis (1993) 1.11
alpha-L-Iduronidase deficiency in mucopolysaccharidosis type I against a radiolabelled sulfated disaccharide substrate derived from dermatan sulfate. Clin Genet (1984) 1.10
Defective lysosomal egress of free sialic acid (N-acetylneuraminic acid) in fibroblasts of patients with infantile free sialic acid storage disease. J Biol Chem (1989) 1.10
Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy. Hum Mutat (2004) 1.09
Human glucosamine-6-sulfatase cDNA reveals homology with steroid sulfatase. Biochem Biophys Res Commun (1988) 1.09
Human N-acetylgalactosamine-4-sulphatase biosynthesis and maturation in normal, Maroteaux-Lamy and multiple-sulphatase-deficient fibroblasts. Biochem J (1990) 1.09
Hyaluronic acid: a novel, double helical molecule. Science (1973) 1.09
Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI. J Clin Invest (1997) 1.08
The crystal structure of poplar apoplastocyanin at 1.8-A resolution. The geometry of the copper-binding site is created by the polypeptide. J Biol Chem (1984) 1.08
Detection of Morquio A syndrome using radiolabelled substrates derived from keratan sulphate for the estimation of galactose 6-sulphate sulphatase. Clin Sci (Lond) (1983) 1.07
A cDNA clone for human glucosamine-6-sulphatase reveals differences between arylsulphatases and non-arylsulphatases. Biochem J (1992) 1.07
Chromosomal localization of the human alpha-L-iduronidase gene (IDUA) to 4p16.3. Am J Hum Genet (1990) 1.05
Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino)ethyl]acridine-4-carboxamide bound to the DNA hexanucleotide d(CGTACG)2. Biochemistry (1999) 1.04
Evolution of a light-harvesting protein by addition of new subunits and rearrangement of conserved elements: crystal structure of a cryptophyte phycoerythrin at 1.63-A resolution. Proc Natl Acad Sci U S A (1999) 1.04
The structure and composition of cartilage keratan sulphate. Biochem J (1974) 1.04
Effect of high dose, repeated intra-cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice. Genes Brain Behav (2008) 1.04
Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies. Biochim Biophys Acta (1998) 1.04
Regulation of insulin receptor metabolism. Differentiation-induced alteration of receptor synthesis and degradation. J Biol Chem (1981) 1.04
Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS. Mol Genet Metab (1998) 1.03
Active site of trypanothione reductase. A target for rational drug design. J Mol Biol (1992) 1.02
A novel missense mutation in lysosomal sulfamidase is the basis of MPS III A in a spontaneous mouse mutant. Glycobiology (2001) 1.02
Characterization of a deletion at Xq27-q28 associated with unbalanced inactivation of the nonmutant X chromosome. Am J Hum Genet (1992) 1.02
Crystal structure of plastocyanin from a green alga, Enteromorpha prolifera. J Mol Biol (1990) 1.02
Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients. Am J Hum Genet (1991) 1.01
Studies on the polydispersity and heterogeneity of cartilage proteoglycans. Identification of 3 proteoglycan structures in bovine nasal cartilage. Biochem J (1975) 1.01
Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mol Genet (1993) 1.00
Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients. Am J Hum Genet (1996) 1.00